Press release:
Beginning today, Oct. 21, Batavia Radiation Oncology Associates, now part of UR Medicine Wilmot Cancer Institute, will close for several weeks for renovations.
The renovations on the building will include the addition of an outpatient blood draw laboratory, larger clinical examination rooms, as well as space to provide medical oncology and infusion services. Significant information technology upgrades will also be made so that medical records and other information can be shared across the Wilmot Cancer Institute network.
The project is expected to be completed by the end of December.
During the construction, patients undergoing treatment through Batavia Radiation Oncology have been scheduled to be seen at either the Pluta Cancer Center in Henrietta or the Cancer Center at Park Ridge in Greece.
Kevin J. Mudd, M.D., who has been medical director for Batavia Radiation Oncology since 2000, will continue to see patients as a member of the University of Rochester Medical Center faculty.
Throughout the project, Mudd and his staff will be available by telephone at (585) 344-3050.
With the renovated and expanded space, the clinic will provide fully integrated cancer care, incorporating both radiation therapy and chemotherapy, as well as access to clinical trials. The chemotherapy services are expected to be available in Batavia by Spring.
These renovations will allow us to offer more comprehensive care closer to home for our patients from Batavia and neighboring communities” said Jonathan W. Friedberg, M.D., M.M.Sc., director of Wilmot Cancer Institute.
The Wilmot Cancer Institute is the Finger Lakes Region’s leader for cancer care and research. As part of UR Medicine, Wilmot provides specialty cancer services at the University of Rochester Medical Center and at a network of satellite locations. Wilmot Cancer Institute is a component of Strong Memorial Hospital. The Institute also includes a team of scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care.
